$57.54
-$0.17
(-0.29%)
Quote as of 4:01 PM EST on 02/10/12
Quest Diagnostics, Inc.
NYSE:DGX
Becton Dickinson Still A Fine Specimen (BDX, DGX, LH, HMA)
Earning Scorecard: Quest Diagnostics - Analyst Blog
Earning Scorecard: Quest Diagnostics
Quest Diagnostics management to meet with Lazard Capital
'Bridging theory and practice'
Jefferies Raises Price Target On Quest Diagnostics (DGX) to $66
Quest Offers Electronic Heath Record Grants
Quest Diagnostics Inc. (DGX) Set Over A 6-Month High After Q4 Report
Greek Default? Investors Just Ready to Move On (EMC, COH, HOG, DGX, BTX, EFOI)
Quest Diagnostics Increases on Plan for $1 Billion Buyback: New York Mover
Quest Diagnostics' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Quest's EPS Beats, Revs In Line
Quest Diagnostics sees FY12 CapEx approximately $225-$250M
Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012
Quest Diagnostics, Inc. (DGX) Tops Q4 EPS Views; Guides FY12 EPS Below Views
Quest Diagnostics sees FY12 EPS $4.40-$4.55 vs. consensus $4.66
Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012
Quest Diagnostics Increases Share Repurchase Authority by $1 Billion
Quest Diagnostics Increases Share Repurchase Authority by $1 Billion
FDA Nod for Quest's STRATIFY JCV - Analyst Blog
FDA Nod for Quest's STRATIFY JCV
Quest Diagnostics: Earnings Preview
Earnings Preview: Quest Diagnostics - Analyst Blog
FDA Allows Marketing Of Quest's First Stratify JCV Antibody ELISA Test
Earnings Preview: Quest Diagnostics
Macquarie Downgrades Quest Diagnostics (DGX) to Neutral
Quest Diagnostics downgraded to Underperform from Neutral at Macquarie
Quest Diagnostics Launches National EHR Grant Program for Physicians
$100M Gender Bias Suit Filed Against Quest Diagnostics in New Jersey
Piper Jaffray's medtech research team holds a conference call
Quest Diagnostics faces gender discrimination class action lawsuit
Gender bias suit filed against Quest Diagnostics
Gender bias suit filed against Quest Diagnostics
Sanford Wittels & Heisler Files $100 Million Employment Class Action:
Aberdeen reports 5.91% passive stake in Quest Diagnostics
